Stocktoria
Encompass Health Corp EHC
Encompass Health Corp (EHC) earns a Piotroski F-score of 7/9 (strong financial health). It pays a dividend yielding 0.71% (safety: safe). FY2025 revenue was $5.9B at a 9.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-10 | TD Cowen | Buy (main) |
| 2026-08-07 | UBS | Buy (main) |
| 2026-08-07 | Truist Securities | Buy (main) |
| 2026-08-06 | Barclays | Overweight (main) |
| 2026-05-28 | TD Cowen | Buy (init) |
| 2026-05-05 | Barclays | Overweight (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| EHC | Encompass Health Corp | 7/9 | — | 17.8 | +10.5% |
| SEM | SELECT MEDICAL HOLDINGS CORP | 5/9 | 1.45 | 14 | +5.1% |
| MD | Pediatrix Medical Group, Inc. | 6/9 | 2.05 | 12.3 | -4.9% |
| JRSS | JRSIS HEALTH CARE Corp | 6/9 | -7.26 | — | — |
| GOOG | Alphabet Inc. | 5/9 | 6.79 | 31.1 | +15.1% |
| MSFT | MICROSOFT CORP | 6/9 | 4.49 | 20.7 | +17.8% |
| META | Meta Platforms, Inc. | 4/9 | 5.34 | 23.1 | +22.2% |
About Encompass Health Corp
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
FAQ
Is EHC financially healthy?
Encompass Health Corp's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak).
Does EHC pay a dividend, and is it safe?
Yes. Encompass Health Corp pays a dividend yielding about 0.71% with a 12.6% payout ratio, rated “safe” for safety.
How profitable is EHC?
In FY2025, Encompass Health Corp had a net margin of 9.5% and a return on equity of 17.6%.
Is EHC overvalued or undervalued?
Encompass Health Corp trades at about 22.5× trailing earnings — above its 10-year norm (10-year range 11.9×–23.1×, median 18.1×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for EHC?
The average Wall-Street price target for Encompass Health Corp is $148.17, about 18.7% above the recent price, from 12 analysts (consensus: strong buy).
Is EHC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Encompass Health Corp: a Piotroski F-score of 7/9, a P/E of about 17.8×, a dividend yield of 0.71%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.